Susceptibility testing of Candida glabrata clinical strains to echinocandins using SensititreTM YeastOneTM system

Susceptibility testing of Candida glabrata clinical strains to echinocandins using SensititreTM YeastOneTM system

Objective. To determine susceptibility of C. glabrata isolates to anidulafungin, caspofungin and micafungin using the SensititreTM YeastOneTM system. Materials and Methods. C. glabrata isolates were taken prospectively from clinical specimens or from strains collections in the participating site...

Full description

Bibliographic Details
Main Authors:	Veselov A.V., Vasilyeva N.V., Bogomolova T.S., Raush E.R., Kutsevalova O.Yu., Nizhegorodceva I.A., Petrova L.V., Shmidt N.V., Moskvitina E.N., Sukhorukova M.V., Ivanchik N.V., Kozlov R.S.
Format:	Article
Language:	Russian
Published:	Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2018-02-01
Series:	Клиническая микробиология и антимикробная химиотерапия
Subjects:	сandida glabrata candidiasis echinocandins resistance
Online Access:	https://cmac-journal.ru/publication/2018/1/cmac-2018-t20-n1-p049/cmac-2018-t20-n1-p049.pdf

Similar Items

Candida glabrata Resistance to Echinocandins Associated with FKS Genes Mutations: How Urgent is the Problem?
by: Veselov A.V.
Published: (2016-05-01)

The problem of systemic candidosis after transplantation of solid organs. Review of the literature
by: S. V. Zhuravel, et al.
Published: (2018-08-01)

Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip
by: Lo Cascio G, et al.
Published: (2022-10-01)

Some issues of the resistance of Candida glabrata to echinocandins
by: Veselov A.V.
Published: (2019-12-01)

The current place of echinocandins in the treatment and prophylaxis of invasive fungal infections
by: Veselov A.V.
Published: (2020-10-01)

Review on Current Status of Echinocandins Use
by: Martyna Mroczyńska, et al.
Published: (2020-05-01)

FDA-Approved Antibacterials and Echinocandins
by: Othman Al Musaimi
Published: (2025-02-01)

Comparative evaluation of Sensititre YeastOne and CLSI M38-Ed3 reference method for determining echinocandin minimum effective concentrations against Aspergillus isolates
by: Assaf Potruch, et al.
Published: (2024-10-01)

Recent Insights into the Paradoxical Effect of Echinocandins
by: Johannes Wagener, et al.
Published: (2017-12-01)

The in vitro Activity of Echinocandins Against Clinical Trichophyton rubrum Isolates and Review of the Susceptibility of T. rubrum to Echinocandins Worldwide
by: Su H, et al.
Published: (2023-08-01)

Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance
by: Francesca Gioia, et al.
Published: (2020-12-01)

Impact of Obesity on Echinocandin Effectiveness in Treating Candida Infections: A Retrospective Observational Cohort Study
by: Aljohani A, et al.
Published: (2024-07-01)

Efficacy and safety of triazoles versus echinocandins in the treatment of invasive aspergillosis: A meta-analysis
by: Uzelac Sanja M., et al.
Published: (2020-01-01)

Treatment of candidemia in a nationwide setting: increased survival with primary echinocandin treatment
by: Lausch KR, et al.
Published: (2018-11-01)

Two echinocandin-resistant Candida glabrata FKS mutants from South Africa
by: Serisha D. Naicker, et al.
Published: (2016-03-01)

Evaluation of Fluconazole versus Echinocandins for Treatment of Candidemia Caused by Susceptible Common <i>Candida</i> Species: A Propensity Score Matching Analysis
by: Jong Hun Kim, et al.
Published: (2023-05-01)

Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
by: Yating Ning, et al.
Published: (2023-12-01)

MOB-mediated regulation of septation initiation network (SIN) signaling is required for echinocandin-induced hyperseptation in Aspergillus fumigatus
by: Harrison I. Thorn, et al.
Published: (2024-03-01)

Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features
by: Noelia Pérez-González, et al.
Published: (2023-04-01)

Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis
by: Ensieh Lotfali, et al.
Published: (2022-06-01)

In Vitro Characterization of Twenty-One Antifungal Combinations against Echinocandin-Resistant and -Susceptible <i>Candida glabrata</i>
by: Hazim O. Khalifa, et al.
Published: (2021-02-01)

The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates
by: Débora Alves Nunes Mario, et al.
Published: (2012-05-01)

Echinocandin-Induced Microevolution of <named-content content-type="genus-species">Candida parapsilosis</named-content> Influences Virulence and Abiotic Stress Tolerance
by: Csaba Papp, et al.
Published: (2018-12-01)

Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
by: Kelley R. Healey, et al.
Published: (2018-09-01)

Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication
by: Francis Vekeman, et al.
Published: (2018-08-01)

Echinocandins as Biotechnological Tools for Treating <i>Candida auris</i> Infections
by: Elizabete de Souza Cândido, et al.
Published: (2020-09-01)

Expansion of a recent class of broad-spectrum antifungal agents: the echinocandins
by: Roberto Manfredi
Published: (2009-09-01)

Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular Characterization
by: Olga Rivero-Menendez, et al.
Published: (2019-07-01)

<i>Candida albicans</i> Genes Modulating Echinocandin Susceptibility of Caspofungin-Adapted Mutants Are Constitutively Expressed in Clinical Isolates with Intermediate or Full Resistance to Echinocandins
by: Anshuman Yadav, et al.
Published: (2024-03-01)

Echinocandin persistence directly impacts the evolution of resistance and survival of the pathogenic fungus Candida glabrata
by: Amir Arastehfar, et al.
Published: (2024-04-01)

Prescribing patterns of echinocandins in adult patients in a private hospital in Gauteng, South Africa
by: Anja Grey, et al.
Published: (2023-03-01)

Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant Cells
by: Rocio Garcia-Rubio, et al.
Published: (2021-08-01)

In vitro synergy of echinocandins with triazoles against fluconazole-resistant Candida parapsilosis complex isolates
by: Ali Ahmadi, et al.
Published: (2020-06-01)

Candida spp. with Acquired Echinocandin Resistance, France, 2004–2010
by: Eric Dannaoui, et al.
Published: (2012-01-01)

Effectiveness and safety of echinocandins combination therapy with the standard of care compared to the standard of care monotherapy for the treatment of invasive aspergillosis infection: a meta-analysis
by: Yazed Saleh Alsowaida, et al.
Published: (2024-12-01)

Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications
by: Sepideh Mehravar, et al.
Published: (2024-03-01)

Whole genome analysis of echinocandin non-susceptible Candida Glabrata clinical isolates: a multi-center study in China
by: Yi Li, et al.
Published: (2023-11-01)

The Emergence of Echinocandin-Resistant <i>Candida glabrata</i> Exhibiting High MICs and Related <i>FKS</i> Mutations in Turkey
by: Ali Korhan Sig, et al.
Published: (2021-08-01)

Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit
by: Niki Dermitzaki, et al.
Published: (2024-12-01)

Pan-Echinocandin Resistant <i>C. parapsilosis</i> Harboring an F652S Fks1 Alteration in a Patient with Prolonged Echinocandin Therapy
by: Maria Siopi, et al.
Published: (2022-09-01)